Skip to content

Development of Visual Function Evaluation Method (2)

Calibration of Visual Function Evaluation Tests in Patients With Severe Vision Loss

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03626207
Enrollment
8
Registered
2018-08-10
Start date
2018-10-04
Completion date
2019-06-26
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinitis Pigmentosa

Keywords

Retinitis pigmentosa, Visual function evaluation

Brief summary

The objective of this study is to develop the comprehensive visual function evaluation method in severe visually impaired patient.

Interventions

None listed

Sponsors

Astellas Pharma Inc
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with severe visual disturbance (count-fingers or worse vision for severe eyes) at the time of obtaining the consent and at screening

Exclusion criteria

* Subjects should not have participated in any other clinical trial or clinical study involving visual function evaluation within 6 months * History of surgery, past history, and complications (cardiac/ hepatic/ renal/ respiratory/ hematological diseases, optic nerve diseases causing marked loss of visual field, and uveitis etc.) that potentially affect evaluation and safety of the study * Pregnant women * Subjects who are judged that continuation of the study is difficult during the study period * Subjects who are employed by the company sponsoring this study, an organization or institution related to this study

Design outcomes

Primary

MeasureTime frameDescription
Slit-lamp-microscopyUp to 3 monthsTo assess the visual function.
Optical Coherence Tomography (OCT) testDay 1To assess the visual function.
Early Treatment Diabetic Retinopathy Study (ETDRS)Up to 3 monthsTo assess the visual function.
The 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25)Up to 3 monthsNEI VFQ 25 is a questionnaire intended to measure visual function and quality of life. It has 25 questions. The original response of each item are coded as per the NEI VFQ scoring system ranging from 0 (worst) to 100 (best).
The 11-item National Eye Institute Visual Function Questionnaire (NEI VFQ-11)Up to 3 monthsNEI VFQ 11 is a questionnaire intended to measure visual function and quality of life. It has 11 questions. The original response of each item are coded as per the NEI VFQ scoring system ranging from 0 (worst) to 100 (best).
Nottingham Adjustment Scale Japanese Version (NAS-J)Up to 3 monthsNAS-J is the Japanese version of NAS which measures psychological adjustment to the visual impairment, and to assess its validity and reliability. The NAS is composed of 7 psychological subscales including anxiety-depression, self-esteem, attitude to disability, locus of control, acceptance of disability, self-efficacy and attributional style. The original response of each item are coded as per the NAS-J scoring system ranging from 0 (lowest psychological adjustment) to 100 (highest psychological adjustment).
Daily living task dependent on vision (DLTV) questionnaireUp to 3 monthsDLTV is a quality of life questionnaire composed of 22 items to obtain estimates of self-reported ability to perform vision-related tasks in persons with visual impairment. Participants rate items on a four-point scale, with Can't see to do (score, 1), A lot of difficulty (score, 2), A little difficulty (score, 3), andNo difficulty (score, 4). The original response of each item are coded as per the DLTV scoring system ranging from 0 (worst) to 100 (best).
Table testUp to 3 monthsTo assess the visual function.
Monitor testUp to 3 monthsTo assess the visual function.
Pupillary function testUp to 3 monthsTo assess the visual function.
Full field stimulus threshold testing (FST)Up to 3 monthsTo assess the visual function.
White flash visual evoked potential (VEP) testUp to 3 monthsTo assess the visual function.
Color flash VEP testUp to 3 monthsTo assess the visual function.
Electrically evoked response (EER) testUp to 3 monthsTo assess the visual function.
White flash Electroretinography (ERG) testDay 1To assess the visual function.
Multifocal ERG testUp to 3 monthsTo assess the visual function.

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026